Beth Hecht insider trades: Xeris Biopharma Holdings (XERS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Beth reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | XERS | ↓ Sell | 25,000 | $10.23 | $256K | Direct | Nov 4, 2026 (2d) |
| Oct 1, 2026 | XERS | ↓ Sell | 16,666 | $9.41 | $157K | Direct | Oct 2, 2026 (1d) |
| Sep 1, 2026 | XERS | ↓ Sell | 16,666 | $8.49 | $141K | Direct | Sep 1, 2026 (0d) |
| Aug 3, 2026 | XERS | ↓ Sell | 16,666 | $8.01 | $134K | Direct | Aug 4, 2026 (1d) |
| Jul 1, 2026 | XERS | ↓ Sell | 16,666 | $8.03 | $134K | Direct | Jul 2, 2026 (1d) |
| Jun 1, 2026 | XERS | ↓ Sell | 16,667 | $6.06 | $101K | Direct | Jun 2, 2026 (1d) |
| Apr 1, 2026 | XERS | ↓ Sell | 16,667 | $5.99 | $100K | Direct | Apr 3, 2026 (2d) |
| Mar 2, 2026 | XERS | ↓ Sell | 16,667 | $6.25 | $104K | Direct | Mar 4, 2026 (2d) |
| Feb 2, 2026 | XERS | ↓ Sell | 16,667 | $7.45 | $124K | Direct | Feb 2, 2026 (0d) |
| Jan 2, 2026 | XERS | ↓ Sell | 16,667 | $7.43 | $124K | Direct | Jan 5, 2026 (3d) |
| Dec 1, 2025 | XERS | ↓ Sell | 16,667 | $7.01 | $117K | Direct | Dec 2, 2025 (1d) |
| Nov 11, 2025 | XERS | ↓ Sell | 16,667 | $7.40 | $123K | Direct | Nov 13, 2025 (2d) |
| Mar 20, 2025 | XERS | ↓ Sell | 40,000 | $5.43 | $217K | Direct | Mar 21, 2025 (1d) |
| Mar 13, 2020 | XERS | ↑ Buy | 4,000 | $1.97 | $8K | Direct | Mar 16, 2020 (3d) |
| Feb 14, 2020 | XERS | ↑ Buy | 4,000 | $4.15 | $17K | Direct | Feb 18, 2020 (4d) |
| Feb 19, 2019 | XERS | ↑ Buy | 2,500 | $10.00 | $25K | Direct | Feb 22, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other XERS insiders
Open-market trades in the last 12 months
About Beth Hecht's insider trades
Beth Hecht is See Remarks at Xeris Biopharma Holdings (XERS). Since Feb 19, 2019, Beth has reported 3 open-market purchases worth $49K and 13 sales worth $1.8M on SEC Form 4. In the last 12 months: 12 sales ($1.6M).
Their filings also include grants and awards (22 filings), shares withheld for taxes (4 filings), option exercises (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XERS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.